Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › PA › EASTON › ST. LUKE'S HOSPITAL- EASTON CAMPUS

ST. LUKE'S HOSPITAL- EASTON CAMPUS

NPI: 1073047981 · EASTON, PA 18042 · General Acute Care Hospital · NPI assigned 04/18/2017

$8.79M
Total Medicaid Paid
157,440
Total Claims
145,434
Beneficiaries
137
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialBOTEK, FRANCINE (SENIOR VP FINANCE)
NPI Enumeration Date04/18/2017

Related Entities

Other providers sharing the same authorized official: BOTEK, FRANCINE

ProviderCityStateTotal Paid
ST LUKE'S HOSPITAL LEHIGHTON PA $638K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 871 $52K
2019 3,979 $96K
2020 13,200 $474K
2021 65,989 $3.77M
2022 27,323 $1.70M
2023 26,081 $1.53M
2024 19,997 $1.16M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 19,008 18,270 $2.60M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 27,352 24,687 $2.35M
99284 Emergency department visit for the evaluation and management, high severity 10,917 10,461 $1.57M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 4,008 3,793 $535K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 3,218 3,186 $367K
G0378 Hospital observation service, per hour 383 344 $248K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2,875 2,782 $176K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4,068 3,904 $142K
74177 Computed tomography, abdomen and pelvis; with contrast material 762 731 $119K
80053 Comprehensive metabolic panel 10,420 9,789 $101K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 13,308 12,374 $65K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 5,183 4,766 $54K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 4,793 4,527 $38K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 757 701 $37K
80050 General health panel 765 754 $31K
70450 Computed tomography, head or brain; without contrast material 504 482 $27K
71275 Computed tomographic angiography, chest, with contrast material 112 108 $21K
71045 Radiologic examination, chest; single view 3,302 3,183 $20K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 386 339 $19K
80048 Basic metabolic panel (calcium, ionized) 1,812 1,735 $14K
X0616 86 86 $13K
74176 Computed tomography, abdomen and pelvis; without contrast material 203 199 $13K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 32 32 $13K
80061 Lipid panel 911 894 $11K
83880 368 352 $10K
83735 1,563 1,497 $10K
83690 2,067 1,982 $10K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 249 238 $9K
87631 48 48 $7K
71046 Radiologic examination, chest; 2 views 666 652 $6K
81001 2,491 2,394 $6K
84484 1,045 938 $6K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 211 207 $6K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring 23 23 $6K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 352 275 $5K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring 13 13 $5K
87040 303 289 $5K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 249 239 $5K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 249 239 $5K
84443 Thyroid stimulating hormone (TSH) 336 312 $5K
76705 Ultrasound, abdominal, real time with image documentation; limited 190 179 $5K
73630 454 391 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 172 167 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 104 94 $4K
85379 412 396 $4K
87086 Culture, bacterial; quantitative colony count, urine 600 563 $4K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 192 177 $4K
OP250 1,821 1,212 $3K
83605 570 527 $3K
36415 Collection of venous blood by venipuncture 3,318 2,693 $3K
86803 167 166 $3K
84702 167 142 $3K
81003 985 931 $2K
84703 244 240 $2K
72125 Computed tomography, cervical spine; without contrast material 51 48 $2K
85730 507 482 $2K
83036 Hemoglobin; glycosylated (A1C) 378 370 $2K
85027 376 356 $2K
85610 729 663 $2K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 148 148 $2K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 27 27 $2K
73610 135 127 $2K
80076 140 137 $2K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 13 12 $2K
70498 14 13 $2K
70496 13 12 $1K
73130 151 129 $1K
96361 Intravenous infusion, hydration; each additional hour 56 49 $1K
J7030 Infusion, normal saline solution , 1000 cc 547 482 $1K
71250 27 26 $1K
99281 Emergency department visit for the evaluation and management, self-limited or minor 16 16 $992.40
J1170 Injection, hydromorphone, up to 4 mg 112 79 $938.19
87186 120 117 $900.00
87077 116 112 $846.27
J1885 Injection, ketorolac tromethamine, per 15 mg 5,614 4,542 $836.35
82805 28 26 $832.38
87070 118 117 $813.15
82550 125 118 $741.12
82728 59 56 $618.00
85007 170 161 $567.49
82948 362 295 $525.54
J2270 Injection, morphine sulfate, up to 10 mg 423 381 $520.39
73564 45 43 $471.90
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 28 28 $444.31
73030 55 53 $427.91
73140 33 31 $422.76
76801 14 14 $418.98
J3490 Unclassified drugs 132 84 $367.57
84145 25 24 $363.83
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,364 3,017 $343.74
83540 49 49 $339.89
90715 49 43 $332.17
82077 102 95 $323.16
82570 45 45 $296.06
82803 19 15 $286.66
82043 37 37 $263.71
88305 Level IV - Surgical pathology, gross and microscopic examination 40 39 $218.70
84439 28 28 $218.24
84153 12 12 $213.40
86140 79 78 $204.43
81025 161 151 $186.47
86592 42 41 $175.47
J2704 Injection, propofol, 10 mg 1,392 976 $166.20
86901 46 44 $163.88
86900 46 44 $161.95
82607 12 12 $149.35
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,438 1,328 $148.79
J2060 Injection, lorazepam, 2 mg 447 372 $127.91
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 41 41 $118.77
J1200 Injection, diphenhydramine hcl, up to 50 mg 732 670 $117.57
82330 19 16 $113.29
83550 25 25 $83.40
J7050 Infusion, normal saline solution, 250 cc 138 76 $78.78
J2765 Injection, metoclopramide hcl, up to 10 mg 705 655 $71.61
J3010 Injection, fentanyl citrate, 0.1 mg 647 564 $69.01
87088 13 12 $64.00
84295 15 12 $61.88
87081 16 14 $61.25
84132 16 13 $60.35
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 16 14 $59.04
85014 19 16 $37.87
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 668 644 $37.00
87205 13 13 $36.36
82947 17 14 $33.28
J0696 Injection, ceftriaxone sodium, per 250 mg 13 13 $19.40
J2250 Injection, midazolam hydrochloride, per 1 mg 448 432 $5.08
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 69 58 $0.01
J3475 Injection, magnesium sulfate, per 500 mg 97 93 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 29 27 $0.00
J1171 Injection, hydromorphone, 0.1 mg 15 12 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 14 13 $0.00
J0690 Injection, cefazolin sodium, 500 mg 335 295 $0.00
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) 59 46 $0.00
96375 Therapeutic injection; each additional sequential IV push 42 42 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 72 69 $0.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 17 13 $0.00
J1630 Injection, haloperidol, up to 5 mg 21 15 $0.00